darolutamide

kallikrein related peptidase 3 ; Homo sapiens







4 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 34843630 Combination therapy with novel androgen receptor antagonists and statin for castration-resistant prostate cancer. 2022 Feb 1
2 32274540 [Treatment of metastatic, castration-resistant prostate cancer]. 2020 Jun 2
3 32765070 Darolutamide: An Evidenced-Based Review of Its Efficacy and Safety in the Treatment of Prostate Cancer. 2020 2
4 30197098 Clinical Development of Darolutamide: A Novel Androgen Receptor Antagonist for the Treatment of Prostate Cancer. 2018 Oct 1